A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation.
Saved in:
| Title: | A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation. |
|---|---|
| Authors: | Simeone, Ester1 (AUTHOR), Scognamiglio, Giosuè1 (AUTHOR), Capone, Mariaelena1 (AUTHOR), Giannarelli, Diana2 (AUTHOR), Grimaldi, Antonio M.1 (AUTHOR), Mallardo, Domenico1 (AUTHOR), Madonna, Gabriele1 (AUTHOR), Curvietto, Marcello1 (AUTHOR), Esposito, Assunta1 (AUTHOR), Sandomenico, Fabio1 (AUTHOR), Sabbatino, Francesco3 (AUTHOR), Bayless, Nicholas L.4 (AUTHOR), Warren, Sarah5 (AUTHOR), Ong, SuFey5 (AUTHOR), Botti, Gerardo1 (AUTHOR), Flaherty, Keith T.6 (AUTHOR), Ferrone, Soldano6 (AUTHOR), Ascierto, Paolo A.1 (AUTHOR) paolo.ascierto@gmail.com |
| Source: | Journal of Translational Medicine. 1/6/2021, Vol. 19 Issue 1, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14795876 |
|---|---|
| DOI: | 10.1186/s12967-020-02680-7 |
